(Q36047324)

English

Prognostic factors in non-Hodgkin's lymphoma: the importance of symptomatic stage as an adjunct to the Kiel histopathological classification

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Prognostic factors in non-Hodgkin's lymphoma: the importance of symptomatic stage as an adjunct to the Kiel histopathological classification (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

Leonard RC

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Cuzick J

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

MacLennan IC

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Vanhegan RI

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Mackie PH

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

McCormick CV

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

1 January 1983

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

47

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

91-102

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Primary gastrointestinal lymphoma: a 30-year review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

2 October 2017

Report of the Committee on Hodgkin's Disease Staging Classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

2 October 2017

Immunochemical quantitation of antigens by single radial immunodiffusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

2 October 2017

Significance of Haematological Parameters in the Non‐Hodgkin's Malignant Lymphomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

2 October 2017

A retrospective analysis of the clinical results in relation to the Rappaport histological classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

2 October 2017

Non-Hodgkin's lymphomata: clinical and immunological data in relation to histology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

2 October 2017

Factors predicting for response and survival in adults with advanced non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

2 October 2017

Survival of patients with localized histiocytic lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

2 October 2017

Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

2 October 2017

Curability of non-Hodgkin's lymphomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

2 October 2017

Chemotherapy of the non-Hodgkin's lymphomas: the Stanford experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

2 October 2017

Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

2 October 2017

Advanced diffuse histiocytic lymphoma, a potentially curable disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

2 October 2017

Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

11 July 2018

Nodular non-Hodgkin's lymphoma (NHL):Factors influencing prognosis and indications for aggressive treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

11 July 2018

Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

11 July 2018

Why not adhere to the original Kiel classification?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011241

23 September 2018

Multivariate analysis of prognostic factors in the non-Hodgkin's malignant lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/6821635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence, cytology, and histopathology of non-Hodgkin's lymphomas in the bone marrow

1 reference

https://pubmed.ncbi.nlm.nih.gov/6821635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term remission in diffuse histiocytic lymphoma treated with combination sequential chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/6821635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced non-Hodgkin's lymphomas with favorable histologies: preliminary results of a prospective trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/6821635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneity of Diffuse Histiocytic Lymphoma According to the Kiel Classification

1 reference

https://pubmed.ncbi.nlm.nih.gov/6821635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Curative radiotherapy for localized diffuse histiocytic lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/6821635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nodular histiocytic lymphoma: factors influencing prognosis and implications for aggressive chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/6821635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1983.11

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36047324&oldid=2198125949"